Novadaq (NVDQ)

[biocqr]

Novadaq Tech. initiated with a Buy at Canaccord Genuity (11.46)

Novadaq Tech.: Initiation details (11.46)

As mentioned earlier Canaccord Genuity initiated NVDQ with a Buy and price target of $15 saying the co possesses a unique technology that they believe could become a standard-of-care intra-operative imaging modality across multiple open and minimally-invasive surgical applications. They think the most appropriate relative comparisons to use to value NVDQ are other high- growth med-tech companies whose technologies possess similar attributes -- i.e., established or emerging standard of care, addresses nascent growth markets, and is improving outcomes for patients.


Read more: http://www.briefing.com/InPlayEq/InPlay/InPlayDual.htm#ixzz29kaG5ta1